本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Revolution Medicines, Inc.

53.49
-0.5200-0.96%
盘后53.490.00000.00%19:44 EDT
成交量:160.59万
成交额:8,689.10万
市值:99.99亿
市盈率:-11.82
高:55.20
开:54.76
低:53.17
收:54.01
52周最高:62.40
52周最低:29.17
股本:1.87亿
流通股本:1.59亿
量比:0.62
换手率:1.01%
股息:- -
股息率:- -
每股收益(TTM):-4.5252
每股收益(LYR):-3.5776
净资产收益率:-46.61%
总资产收益率:-26.47%
市净率:5.36
市盈率(LYR):-14.95

数据加载中...

2024/07/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/24

重要事件披露

Form 8-K - Current report
2024/06/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/05/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/19

SEC问询函

Form CORRESP - Correspondence
2024/04/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities